US Patent Issued to ANTECIP BIOVENTURES II on Oct. 21 for "Bupropion as a modulator of drug activity" (New York Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,138, issued on Oct. 21, was assigned to ANTECIP BIOVENTURES II LLC (New York).

"Bupropion as a modulator of drug activity" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan."

The patent was filed on Dec. 8, 2022, under Application No. 18/063,261.

*For further information, including images, charts and tables, please visit: htt...